Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults

NCT02654665 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Non-alcoholic Fatty Liver Disease (NAFLD)
Weight Loss
Non-alcoholic Steatohepatitis (NASH)

Interventions

BEHAVIORAL: Lifestyle modification
DRUG: Liraglutide

Sponsor

Changi General Hospital